Ureter metastatic castration-resistant prostate cancer: a case report

J Med Case Rep. 2017 Sep 6;11(1):215. doi: 10.1186/s13256-017-1379-z.

Abstract

Background: In most cases, prostate cancer metastasizes to the lymph nodes, bone, and liver. In very rare cases, it metastasizes to the ureter. Due to the difficulty in making a preoperative diagnosis, ureteral metastasis from prostate cancer is typically diagnosed after nephroureterectomy.

Case presentation: A 77-year-old Asian Japanese man with right hydronephrosis and hydroureter was referred to our hospital to undergo further examination due to the suspicion of ureteral cancer. He had been diagnosed 2 years previously with prostate cancer with a Gleason score of 4+5=9. He received radiotherapy and androgen deprivation therapy. A nephroureterectomy was performed for suspected right ureteral cancer. On the basis of a histopathological examination, poorly differentiated adenocarcinoma was suspected, and the tumor cells were positive for prostate-specific antigen immunohistochemically.

Conclusions: We herein report a rare case of ureteral metastasis in castration resistant prostate cancer.

Keywords: Female PSA; Skene’s gland adenocarcinoma; Skene’s gland cancer.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma* / diagnosis
  • Adenocarcinoma* / pathology
  • Adenocarcinoma* / surgery
  • Aged
  • Androgen Antagonists / therapeutic use
  • Diagnosis, Differential
  • Humans
  • Hydronephrosis* / diagnosis
  • Hydronephrosis* / etiology
  • Hydronephrosis* / surgery
  • Male
  • Neoplasm Grading
  • Neoplasm Staging
  • Nephroureterectomy / methods*
  • Prostatic Neoplasms, Castration-Resistant / pathology*
  • Radiotherapy / methods
  • Tomography, X-Ray Computed / methods
  • Ureter* / pathology
  • Ureter* / surgery
  • Ureteral Neoplasms* / diagnosis
  • Ureteral Neoplasms* / pathology
  • Ureteral Neoplasms* / secondary
  • Urography / methods

Substances

  • Androgen Antagonists